CRIS Q1 2021 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-19.2% YoY

Gross Profit

$2M95.0% margin

Operating Income

-$9M-402.0% margin

Net Income

-$10M-453.5% margin

EPS (Diluted)

$-2.17

QoQ Revenue Growth

-27.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$191M

Total Liabilities

$69M

Stockholders' Equity

$122M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-19.2%
Gross Profit	$2M	$3M	-19.5%
Operating Income	-$9M	-$8M	-3.7%
Net Income	-$10M	-$10M	-2.2%

Revenue Segments

Gross Royalty Revenue

$2M100%

Contra Revenue

$2,0000%